Sivextro

— THERAPEUTIC CATEGORIES —
  • Bacterial infections

Sivextro Generic Name & Formulations

General Description

Tedizolid phosphate 200mg; tabs.

Pharmacological Class

Oxazolidinone.

How Supplied

Tabs—6 (blister pack), 30; Single-dose vials—10

Generic Availability

NO

Sivextro Indications

Indications

Susceptible acute bacterial skin and skin structure infections (ABSSSI).

Sivextro Dosage and Administration

Adults and Children

<12yrs: not established. ≥12yrs: 200mg once daily for 6 days.

Sivextro Contraindications

Not Applicable

Sivextro Boxed Warnings

Not Applicable

Sivextro Warnings/Precautions

Warnings/Precautions

Not adequately evaluated in patients with neutropenia (ANC <1000 cells/mm3); consider alternate therapies. Risk of C. difficile-associated diarrhea; discontinue if suspected or confirmed. Pregnancy. Nursing mothers.

Sivextro Pharmacokinetics

See Literature

Sivextro Interactions

Interactions

Tabs: May potentiate oral BCRP substrates; consider interrupting co-administered substrates esp. those with narrow therapeutic index (eg, methotrexate, topotecan); monitor if coadministration (including rosuvastatin) is necessary.

Sivextro Adverse Reactions

Adverse Reactions

Nausea, headache, diarrhea, infusion- or inj site reactions, vomiting, dizziness. In children: phlebitis, increased hepatic transaminases.

Sivextro Clinical Trials

See Literature

Sivextro Note

Not Applicable

Sivextro Patient Counseling

See Literature